Maine Code § 24-2320-G

Off-label use of prescription drugs for HIV or AIDS
Open in Lexace · Ask the AI about this section
1. Definitions. As used in this section, unless the context otherwise indicates, the following terms
have the following meanings.
A. "Off-label use" means the prescription and use of drugs for indications other than those stated
in the labeling approved by the federal Food and Drug Administration. [PL 1997, c. 701, §1
(NEW).]
B. "Peer-reviewed medical literature" means scientific studies published in at least 2 articles from
major peer-reviewed medical journals that present data that supports the proposed off-label use as
generally safe and effective. [PL 1997, c. 701, §1 (NEW).]
C. "Standard reference compendia" means:
(1) The United States Pharmacopeia Drug Information or information published by its
successor organization; or
(2) The American Hospital Formulary Service Drug Information or information published by
its successor organization. [PL 1997, c. 701, §1 (NEW).]
[PL 1997, c. 701, §1 (NEW).]

2. Required coverage for off-label use. All individual and group nonprofit hospital and medical
services plan contracts and nonprofit health care plan contracts that provide coverage for prescription
drugs must provide coverage for off-label use in accordance with the following.
A. Individual and group nonprofit hospital and medical services plan contracts and nonprofit health
care plan contracts that provide coverage for prescription drugs may not exclude coverage for any
such drug used for the treatment of HIV or AIDS on the grounds that the drug has not been approved
by the federal Food and Drug Administration for that indication, as long as that drug is recognized
for the treatment of that indication in one of the standard reference compendia or in peer-reviewed
medical literature. [PL 1997, c. 701, §1 (NEW).]
B. Coverage of a drug required by this subsection also includes medically necessary services
associated with the administration of the drug. [PL 1997, c. 701, §1 (NEW).]
C. This subsection may not be construed to require coverage for a drug when the federal Food and
Drug Administration has determined its use to be contraindicated for treatment of the current
indication. [PL 1997, c. 701, §1 (NEW).]
D. A drug use that is covered pursuant to paragraph A may not be denied coverage based on a
"medical necessity" requirement except for a reason that is unrelated to the legal status of the drug
use. [PL 1997, c. 701, §1 (NEW).]
E. A contract that provides coverage of a drug as required by this subsection may contain
provisions for maximum benefits and coinsurance and reasonable limitations, deductibles and
exclusions to the same extent that these provisions are applicable to coverage of all prescription
drugs and are not inconsistent with the requirements of this subsection. [PL 1997, c. 701, §1
(NEW).]
[PL 1997, c. 701, §1 (NEW).]
3. Application. The requirements of this section apply to all policies, contracts and certificates
executed, delivered, issued for delivery, continued or renewed in this State on or after January 1, 1999.
For purposes of this section, all contracts are deemed to be renewed no later than the next yearly
anniversary of the contract date.
[PL 1997, c. 701, §1 (NEW).]

‹ Prev All Maine sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.